203 related articles for article (PubMed ID: 25043306)
1. PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.
Lee KH; Park JW; Sung HS; Choi YJ; Kim WH; Lee HS; Chung HJ; Shin HW; Cho CH; Kim TY; Li SH; Youn HD; Kim SJ; Chun YS
Oncogene; 2015 May; 34(22):2897-909. PubMed ID: 25043306
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase.
Yang J; Ma J; Xiong Y; Wang Y; Jin K; Xia W; Chen Q; Huang J; Zhang J; Jiang N; Jiang S; Ma D
J Cell Physiol; 2018 Sep; 233(9):6841-6852. PubMed ID: 29336484
[TBL] [Abstract][Full Text] [Related]
3. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs.
Sabatino MA; Previdi S; Broggini M
Int J Cancer; 2007 Feb; 120(3):506-13. PubMed ID: 17096333
[TBL] [Abstract][Full Text] [Related]
5. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
6. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
7. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
Wang W; Kim SH; El-Deiry WS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.
Li WF; Herkilini A; Tang Y; Huang P; Song GB; Miyagishi M; Kasim V; Wu SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1888-1899. PubMed ID: 33526870
[TBL] [Abstract][Full Text] [Related]
10. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor functions of miR-133a in colorectal cancer.
Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
[TBL] [Abstract][Full Text] [Related]
12. Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma.
Lee C; Kim B; Song B; Moon KC
J Pathol Transl Med; 2017 Jul; 51(4):359-364. PubMed ID: 28607325
[TBL] [Abstract][Full Text] [Related]
13. HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Ferrandiz N; Martin-Perez J; Blanco R; Donertas D; Weber A; Eilers M; Dotto P; Delgado MD; Leon J
DNA Repair (Amst); 2009 Mar; 8(3):390-9. PubMed ID: 19150257
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
[TBL] [Abstract][Full Text] [Related]
15. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
17. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
18. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.
Fei P; Wang W; Kim SH; Wang S; Burns TF; Sax JK; Buzzai M; Dicker DT; McKenna WG; Bernhard EJ; El-Deiry WS
Cancer Cell; 2004 Dec; 6(6):597-609. PubMed ID: 15607964
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis.
Holla S; Ghorpade DS; Singh V; Bansal K; Balaji KN
Mol Cancer; 2014 Sep; 13():210. PubMed ID: 25208737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
